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Glutamate releaseThemaxi-anion channel has been observed inmany cell types from the very beginning of the patch-clampera. The
channel is highly conductive for chloride and thus canmodulate the restingmembrane potential and play a role in
ﬂuid secretion/absorption and cell volume regulation. A wide nanoscopic pore of the maxi-anion channel permits
passage of excitatory amino acids and nucleotides. The channel-mediated release of these signaling molecules is
associated with kidney tubuloglomerular feedback, cardiac ischemia/hypoxia, as well as brain ischemia/hypoxia
and excitotoxic neurodegeneration. Despite the ubiquitous expression and physiological/pathophysiological sig-
niﬁcance, themolecular identity of themaxi-anion channel is still obscure. VDAC is primarily amitochondrial pro-
tein; however several groups detected it on the cellular surface. VDAC in lipid bilayers reproduced the most
important biophysical properties of the maxi-anion channel, such as a wide nano-sized pore, closure in response
to moderately high voltages, ATP-block and ATP-permeability. However, these similarities turned out to be super-
ﬁcial, and the hypothesis of plasmalemmal VDAC as themaxi-anion channel did not withstand the test by genetic
manipulations of VDAC protein expression. VDAC on the cellular surface could also function as a ferricyanide re-
ductase or a receptor for plasminogen kringle 5 and for neuroactive steroids. These ideas, as well as the very pres-
ence of VDACon plasmalemma, remain to be scrutinized by geneticmanipulations of the VDACprotein expression.
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When studying the cellular surface by patch-clamp, one would rather
neglect events of exceedingly high amplitude. A common rationale is that
too much ﬂux would quickly deteriorate trans-membrane ionic balances
and, thus will be detrimental to the cells. However, from the very begin-
ning of the patch-clamp era, investigators repeatedly and consistently
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tive and have later been classiﬁed as maxi-K, or BK-channels [1]. Some
of them were Cl-conductive and thus were named as maxi-Cl or maxi-
anion channels [2]. For a long time, the maxi-anion channels remained
somewhat out of the mainstream cell physiology due to an exceedingly
large conductance of about 300–400 pS. Gradually, it became evident
that for these channels, the phenomenon is not a high chloride conduc-
tance, but a minute permeability for signaling molecules, such as nucleo-
tides and amino acids, which explains their wide expression and tight
regulation. At present, themaxi-anion channel is considered as an impor-
tant pathway for regulated release of ATP and other nucleotides aswell as
glutamate in the physiologically and pathophysiologically signiﬁcant cell-
to-cell signal transduction [3–6]. However, the molecular entity of this
channel remains obscure. In the present review, we shall summarize
the pros and cons of an idea that the mitochondrial voltage-dependent
anion channel (VDAC) could be expressed at the cellular plasma mem-
brane where it could function as the maxi-anion channel.
2. Expression proﬁle of VDAC
Initially, VDAC has been considered as an exclusively mitochondri-
al protein located on the organelle's outer membrane [7,8]. This no-
tion has been challenged by a group of German scientists, who ﬁrst
suggested that VDAC protein may also be expressed in other cellular
compartments. Thus, Thinnes and co-authors [9] and Kayser and co-
authors [10] puriﬁed a 31 kDa protein from a crude membrane prep-
aration of frozen B lymphocytes and established the ﬁrst primary se-
quence of human porin named Porin 31HL. This sequence was later
used as a template for cloning of human VDAC1 and VDAC2 genes
by Blachly-Dyson and co-authors [11]. Subsequently, a bovine brain-
derived plasmalemmal porin was cloned by microsequencing a 34-
kDa protein band isolated from detergent-resistant membrane frac-
tions and PCR-ampliﬁcation of the respective DNA sequences [12].
The established amino acid sequences allowed generating a set of
monoclonal antibodies against a short (19 amino acids) portion of
the N-terminus [13], and these antibodies were used for immunocy-
tochemical imaging of Porin 31HL expression in skeletal muscle
[13], lymphoid cell lines [14], and airway epithelium [15]. Surprising-
ly, in all the reported images, the antibodies preferentially stained
plasma membranes [16,17]. Initial studies used conventional ﬂuores-
cence microscopy and immunogold electron microscopy methods.
Later, the plasmalemmal expression of VDAC protein has been con-
ﬁrmed by employing a laser scanning confocal microscopy technique
[18–24]. Heterologous expression of GFP- or FLAG-tagged VDAC1 in
Xenopus oocytes also clearly showed a plasmalemmal expression pat-
tern [25]; a similar pattern has been seen for the endogenous Xenopus
VDAC [26].
Plasma membrane proteins are known to be glycosylated. There-
fore, in order to isolate plasmalemmal carbohydrate-enriched protein
fractions, Eben-Brunnen and co-authors [27] passed the crude mem-
brane preparation of cultured human B-lymphocytes through a lentil
lectin column and detected high amounts of type-1 VDAC protein by
Western blotting. Afﬁnity to the PEG and wheat germ agglutinin was
used by Schindler and co-authors [28] in order to obtain highly puri-
ﬁed plasma membrane fraction for subsequent LC–MS/MS analysis,
which revealed the presence of VDAC1 among 146 membrane pro-
teins detected. VDAC1 was also found in the list of 2433 proteins of
the plasma membrane preparation of the cultured melanoma cells
obtained after ultracentrifugation in a sucrose gradient [29].
Biotinylation provides yet another means of speciﬁc membrane
surface labeling. This maneuver was utilized by Jakob and co-authors
in order to decorate the plasma membrane proteins of cultured
human B lymphocytes, among which there was a band stained by
anti-VDAC antibody [30]. Bathori and co-authors [31,32] biotinylated
plasma membranes of cultured neoplastic T-lymphoid CEM cells
using membrane-impermeable NHS–SS–biotin and isolated biotin-labeled low density triton-insoluble fractions, which represent caveo-
lae-containing membrane domains. They isolated VDAC protein from
this fraction and identiﬁed it by Western blotting and electrophysio-
logical recording. In cultured septal and hippocampal neuronal cells
[23] and in membrane preparations from human brain cortex [33],
the VDAC protein was found in caveolae and co-localized with caveo-
lin and estrogene receptor α. Previously, VDAC was detected in the
caveolae preparation obtained from the mouse lung [34]. Note, how-
ever, that VDAC did not co-localize with caveolin-1 in C1300 neuro-
blastoma cells [20], although it did in NIH3T3 ﬁbroblasts [19],
suggesting that microdomain association of VDAC may display cell
type speciﬁcity. VDAC has also been detected in synaptosomes of
Torpedo electric organ [35], which represent yet another extra-mito-
chondrial subcellular destination for this protein.
The red blood cells do not possess mitochondria, endoplasmic re-
ticulum and Golgi apparatus. Shimizu and co-authors [36] detected
the VDAC protein in the total human RBC lysates as well as in the
ghost membranes obtained by osmotic shock. Extracellularly applied
anti-VDAC antibodies strongly suppressed the Bax-induced hemolysis
in this study functionally conﬁrming the VDAC presence on the RBC
plasma membrane; however, the precise mechanism of Bax-induced
cell lysis is yet to be understood in detail.
In sperm cells, the VDAC2 protein was found in the tail of the Dro-
sophila spermatozoa [37], whereas bovine VDAC2 and VDAC3 were
detected in the outer dense ﬁber, a component of ﬂagellum which to-
tally lacks membranes [38,39]. The human VDAC2 was detected in the
acrosomal plasma membrane [40], and porcine oocytes expressed
VDAC1, but not VDAC2, on their plasma membrane [21].
It should be noted, that not all the studies were consistent with
the plasmalemmal expression of VDAC. Thus, in the reports by Yu
and co-authors [41,42], the human VDAC1 and VDAC2 proteins
were tagged with FLAG epitope or human inﬂuenza hemagglutinin-
derived epitope; the constructs then were expressed in COS7 cells
or in cultured astrocytes, and subcellular localization was analyzed
by membrane fractionation, immunocytochemistry, and immunogold
electron microscopy. The heterologously expressed recombinant
VDAC proteins could be detected exclusively in the mitochondria.
The same result was obtained by Massa and co-authors [43], who
stained human and mouse skeletal muscle ﬁbers with anti-VDAC1 an-
tibodies and found immunoreactivity in mitochondria and sarcoplas-
mic reticulum, but not in sarcolemma.
The expression proﬁle studies cited here come from different
groups and rather well-performed by utilizing adequate techniques;
yet the results are rather disparate. One of the reasons could be that
the endogenous expression level of the mitochondrial porin is very
high; therefore, the membrane fractions isolated by differential cen-
trifugation could be contaminated by this highly abundant protein.
Certainly, surface speciﬁc isolation methods, such as binding to lectin
or wheat germ agglutinin, or pre-biotinylation (particularly with
membrane-impermeable biotin derivatives) should largely eliminate
this problem. However, the result will still depend on the balance be-
tween the efﬁciency of membrane fraction separation and the sensi-
tivity of the detection method. This is particularly true for recently
developed mass spectrometry techniques, such as LC–MS/MS. Our
own experience suggested that many mitochondria-speciﬁc proteins,
such as components of the respiratory chain and Krebs cycle, could be
detected by this method in plasma membrane preparations. Cell sur-
face immunostaining patterns observed on intact or permeabilized,
but not destroyed cells cannot be explained by contamination arti-
facts. Most likely, these results reﬂect the actual presence of VDAC
protein on the plasmalemma. Controversial results may reﬂect cell
type speciﬁcity of the membrane trafﬁcking control systems, which
may either restrict the expression exclusively to mitochondria, or
redirect the protein synthesis to the “ER–Golgi–plasmalemma”
pathway by using one of the mechanisms, which we shall discuss
in the next chapter.
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A possible mechanism for alternative targeting the VDAC protein to
different locations has been suggested by Buettner and co-authors [24].
This group isolated overlapping DNA fragments spanning the entire
murine VDAC1 gene and identiﬁed an alternative ﬁrst exon that
encoded a hydrophobic leader peptide at the N-terminus, a signal that
purportedly targets the protein to the plasma membrane through the
Golgi apparatus. Expression of two differentmRNAs, one corresponding
to the mitochondrial VDAC (mt-VDAC) and the other one with addi-
tional sequence for a leader peptide, could be observed by RT-PCR and
Northern blot analysis of whole mouse brain. Heterologous expression
of the plasmid constructs of plasmalemmal VDAC (pl-VDAC) in COS7
cells yielded two bands with molecular masses differing by the value
identical to the size of the leader peptide. Expression of myc- or GFP-
tagged mt-VDAC resulted in a mitochondrial expression pattern,
whereas tagged pl-VDAC was found predominantly in Golgi and endo-
plasmic reticulum areas. Under the proposed scenario, the signal pep-
tide is eventually cleaved away and a protein identical to the
mitochondrial VDAC is produced on the cellular surface. The presence
of mRNA coding for the pl-VDAC signal peptide has been conﬁrmed
by RT-PCR in mouse C1300 neuroblastoma cells [20], mouse NIH3T3 ﬁ-
broblasts [19], in ﬁbroblasts from wild-type, but not vdac1−/− mice
[44], and in mouse mammary C127 cells (Sabirov and Okada, unpub-
lished observation). Thus, signal sequence-basedmechanismof alterna-
tive protein targetingmight be in fact functioning in mice. However, no
such sequence was found for human VDAC1 [45]. Moreover, heterolo-
gous expression of human VDAC1 without any signal sequence pro-
duced a plasmalemmal localization pattern [25]. Therefore, some
other targeting mechanisms need to be invented for human cells. This
could involve alternative mRNA untranslated regions, as suggested by
Bathori and co-authors [32], or trafﬁcking via ER/mitochondria-associ-
ated membranes (MAMs) and plasma membrane/ER associations
(PAMs) as discussed by De Pinto and co-authors [45]. It should be
noted that not only porins, but also other mitochondrial components,
such as minor histocompatibility antigen, aspartate aminotransferase,
fumarase and some others could also be found outside mitochondria
[46]. The mechanisms of such multiple protein localization seem not
to be clearly understood at present.
4. “pl-VDAC=plasma membrane anion channel” hypothesis
Since VDAC reconstituted in artiﬁcial lipid bilayer membranes
functions as an ion channel with large amplitude and preferential
permeability for anions, discoverers of the plasmalemmally expressed
VDAC hypothesized that it may function as an anion channel also on
the cellular plasma membrane. One of the channels claimed to be re-
lated to VDACwas a chloride conductance disregulated in cystic ﬁbro-
sis [47], an idea supported by the immunocolocalization of porin and
CFTR protein in human respiratory epithelium [15]. CFTR is a cAMP-
activated chloride channel, which up-regulates the outwardly rectifying
chloride channel, ORCC [48], but down-regulates the volume-sensitive
outwardly rectifying (VSOR) chloride conductance [49]; both of them
have similar biophysical properties with an intermediate outward con-
ductance of 40–70 pS [3,50,51]. Reymann and co-authors [16] suggested
that, depending on the status of biochemical regulation, VDAC may ex-
hibit properties of themini-Cl channel of about 13 pS, midi-conductance
ORCC (or ORDIC, outwardly rectifying depolarization-induced chloride
channel) of 40–50 pS, or maxi-anion channel of about 400 pS. Gadoli-
num ions at 15–60 μM induced excessive swelling of B-lymphocytes
and HeLa cells, which could be blocked by monoclonal anti-VDAC anti-
bodies [52,53]. Gd3+ decreased the voltage-dependent inactivation
of VDAC, thus it was concluded that VDAC is a part of the ORCC-
type anion channel responsible for cell swelling in isotonic chloride-
or taurine-containing solutions. Anti-VDAC antibodies also blocked
the regulatory volume decrease (RVD) in HeLa cells in response tohypoosmotic stimulation, implying that VDAC may constitute a
part of the volume-sensitive anion channel [54]. VDAC1-defﬁcient
mice, indeed, had poor volume regulation, whereas it was more ro-
bust in pl-VDAC1 overexpressing cells [44]; note, however, that
VDAC-deﬁcient cells had compromised ATP release, and that the ex-
tracellular ATP may enhance the cell volume regulation [51,55–62].
The maxi-anion channel attracted most of the attention as a possible
physiological correlate of the plasmalemmal VDAC, since it has a large
single-channel amplitude, anion selectivity and voltage-dependent inac-
tivation reminiscent of VDAC. Dermietzel and co-authors [12] were ﬁrst
to treat the maxi-anion channel as a plasmalemmal VDAC. The channel
activity recorded from cultured astrocytes in the inside-out patches
was similar to that observed in many other cell types [6], although the
anionic selectivity was somewhat lower. A monoclonal antibody raised
against a 19-amino acid N-terminal part of the brain VDAC protein
effectively inhibited the maxi-anion channel activity in the out-
side-out patch conﬁguration, whereas pre-absorbing the antibody
with the synthetic N-terminal peptide prevented the inhibitory ef-
fect demonstrating speciﬁcity of the antibody blocking effect.
Buettner and co-authors [24] stably transfected the PC12 pheo-
chromocytoma cells with two kinds of plasmids: one corresponding
to the standard mitochondrial VDAC, and the other one that con-
tained a signal peptide to redirect the VDAC to the plasmamembrane.
Patch-clamp analysis of the excised inside-out membrane fragments
revealed the presence of basal large-conductance activity in control
untransfected cells, but the activity was notably enhanced in the sta-
ble transfectants regardless of the plasmid type used for transfection.
The single channels were voltage-dependent with a closed state hav-
ing the conductance of about half of that in the fully open state. This
was similar to the mitochondrial porin, but different from the maxi-
anion channel, which is known to close completely at higher voltages.
Although the authors did not characterize the ionic selectivity of the
recorded events, they interpreted them as maxi-anion channels. An-
other piece of information supporting the hypothesis comes from
Bahamonde and co-authors [20] who found that transfection of
C1300 neuroblastoma cells with antisense oligonucleotides directed
against the signal peptide of the plasmalemmal subtype of VDAC
(the one described in [24]) resulted in the signiﬁcant decrease in
plasmalemmal VDAC-immunostaining and in whole-cell maxi-anion
channel currents activated by an antiestrogen, toremifene. Single
maxi-anion channel activity in the excised inside patches was also de-
creased by the antisense treatment, although the decrease was less
prominent compared to the macroscopic current.
Finally, apoptosis studies were also consistent with the above men-
tioned hypothesis. Elinder and co-authors have demonstrated that the
activity of the maxi-anion channel in mouse hippocampal HT22 cells
was greatly increased by induction of apoptosis with staurosporine
[22], and the apoptosis-induced channel activitywas largely suppressed
bypre-incubation of the cellswith three different antibodies against dif-
ferent VDAC epitopes. The degree of apoptosis was also decreased by
the antibody treatment. These authors measured the ferricyanide re-
ductase activity, which was up-regulated by staurosporine and was
brought back to the control level by the anti-VDAC antibodies. A similar
result was obtained on differentiated primary cultured neurons, but not
with the embryonic neuronal stem cells [18]. Apoptosis-induced maxi-
anion channels had biophysical properties fairly similar to those
recorded in normal non-apoptotic cells [63].
5. VDAC gene deletion/silencing contradicts the “pl-VDAC=maxi-
anion channel” hypothesis
The idea that plasmalemmally expressed VDAC protein functions as
the maxi-anion channel has been very attractive and stimulating.
Studying the channel in mammary C127 cells, we termed it as VDACL:
Volume-Dependent ATP-Conductive Large-conductance anion channel
[64]. We have shown that the channel is activated in response to ATP-
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mammary C127 cells [64], in kidney macula-densa [65], in neonatal
and adult cardiomyocytes [66,67], and cultured astrocytes [68,69]. In
all these cells, the channel was conductive for ATP, the property
which parallels the ATP transport through VDAC protein [70–75]. ATP
produced an open-channel block both for the maxi-anion channel [64]
and VDAC [72–74]. Since it was difﬁcult to imagine that a plasmamem-
brane ion channel could pass such a bulky ion asATP4− orMgATP2−, we
employed an independent method using non-charged polymers, poly-
ethylene glycols [76–80], in order to obtain estimates of the channel
pore size. The polymer-partitioning experiments yielded a pore radius
of around 1.3 nm [81], a value, which was close to the radius of
1.5 nm obtained by the same method for bovine muscle porin-31BM
reconstituted into the lipid bilayers [82–84] and about 1.4 nm from
the electron microscopy data [85,86]. One-sided application of poly-
mers revealed a signiﬁcant asymmetry of the VDAC pore with a radius
of ~1 nm and ~2 nm for its cis- and trans-entrances, respectively (cis
designates the side of the bilayer to which the protein was added)
[82,83]. This asymmetry parallels the non-symmetrical pore of the
maxi-anion channel, which has intracellular and extracellular vesti-
bules of 1.16 nm and 1.42 nm, respectively [81]. Such a large pore
would permit passage of not only ATP, but also smaller signaling mole-
cules. Indeed, release of glutamate induced by osmotic swelling and is-
chemia from cultured astrocytes occurred, in part, via maxi-anion
channel [87]. Thus, our own functional data were compatible with the
idea that the maxi-anion channel activity reﬂects functioning of VDAC
protein on the plasma membrane. However, all of these evidence
should be considered as circumstantial and the only decisive way to
test this hypothesis would be using genetic manipulations to complete-
ly delete the expression of the gene products.
Recent cloning studies identiﬁed three mammalian isoforms of mi-
tochondrial porin: VDAC1, VDAC2 and VDAC3 [11,12,88–95]. Deletion
of vdac genes resulted in various physiological dysfunctions [96,97],
such as male infertility [98], disrupted fear conditioning and spatial
learning [99], susceptibility to apoptosis [100], and growth retardation
and increased fatigue [97]. If the hypothesis of the maxi-anion channel
being a pl-VDAC is valid, then VDAC deletion and/or silencing must
eliminate the channel activity. Sabirov and co-authors [101] patch-
clamped ﬁbroblasts isolated from mice deﬁcient in vdac genes and
found no correlation between the gene expression and maxi-anion
channel activity. The tested mutant cells included individual vdac1,
vdac2 and vdac3 knock-outs and a vdac1/vdac3 double knock-out. All
cells exhibited maxi-anion channel activity indistinguishable from the
wild-type ﬁbroblasts, including activation by patch excision, voltage-
dependent gating, linear current–voltage relationship and unaltered
single-channel conductance as well as K+ to Cl− selectivity. Note that
the “pl-VDAC=maxi-anion channel” hypothesis was formulated by
Buettner and co-authors [24] based on the genomic structure of vdac1
gene. Therefore, the very existence of the maxi-anion channels in the
vdac1−/− cells refuted this idea. Although no results were reported
on the possible signal peptides in vdac2 and vdac3 genes, there is a pos-
sibility that vdac2 and vdac3 gene products functionally replace pl-
VDAC1 in vdac1−/− cells. The result with vdac2−/− and vdac3−/−
suggested that none of the three individual isoforms of VDAC protein
could be responsible for themaxi-anion channel activity inmouseﬁbro-
blasts. Double-deﬁcient vdac1/vdac3 knock-out cells narrowed this pos-
sibility to vdac2. Unfortunately, triple knock-outs were not viable;
therefore, the gene silencing strategy using RNA interference to reduce
the expression of VDAC2 protein in vdac1/vdac3 double knock-out ﬁbro-
blasts was employed. Decreased level of VDAC2 expression in these cells
did not result in signiﬁcant change inmaxi-anion channel activity. These
results strongly argue against the hypothesis that maxi-anion channel
represents VDAC protein on the cellular plasma membrane.
An independent conﬁrmation of this conclusion came from the pl-
VDAC1 expression experiments. We have subcloned pl-VDAC1 gene
(a kind gift from Dr. R. Buettner) into a bicistronic expression vectorwith EGFP reporter gene. Previously, we have shown that a similar con-
struct produced a high level of expression of the CFTR protein and CFTR-
currents [49,77]. However, overexpression of the pl-VDAC protein in
HEK293T cells failed to reproduce the phenotype of the maxi-anion
channel (Fig. 1A, B; Sabirov, Ando-Akatsuka, and Okada, unpublished
observation). Under the same experimental conditions, however, the ﬁ-
broblasts isolated from vdac1/vdac3 double-deﬁcient mice readily dis-
played maxi-anion channel activity upon patch excision (Fig. 1C;
Sabirov, Sheiko, Craigen and Okada, unpublished record). These data
once again demonstrate that the maxi-anion channel activity does not
correlate with the vdac1 gene expression.
6. Biophysical properties of maxi-anion channel and VDAC are
different
As we have already mentioned, the main reason for considering
the maxi-anion channel as pl-VDAC was that the two channels shared
common biophysical properties. However, the similarities are rather
superﬁcial, and closer inspection revealed important differences
[101]. First and most important parameter is the single-channel am-
plitude, which is very large for both channels. For mammalian VDAC
in bilayers, the channel conductance was reported to be 480 pS and
4500 pS in 100 mM and 1 M KCl, respectively [102]. However, these
conditions are far from normally used in maxi-anion channel patch-
clamp studies. In our preliminary experiments, we reconstituted the
VDACprotein from rat livermitochondria (a kind gift fromDrs. S. Shimizu
and Y. Tsujimoto) into the lipid bilayers and recorded single channel
events of about 530 pS in the normal Ringer solution (Fig. 2A). This
value is app. 30–70% higher compared to 300–400 pS reported for the
maxi-anion channels under the same ionic environment [6]. At higher
salt concentrations, themaxi-anion channel conductance is known to sat-
urate at 580–640 pS with Km of 77–120 mM [103–105]. Meanwhile, we
recorded the single VDAC amplitude of 4100 pS in 1 M KCl, and it is
well known that further increase in salt concentration leads to a linear in-
crease in VDAC conductance up to the level of ~10 nSwithout any satura-
tion [106]. Such an immense difference in channel behavior suggests a
principally different mechanism of ionic transport in these two pores.
This inference is supported by comparison of the ionic selectivity of
these two channels. In many cell types, the maxi-anion channel exhibits
superb discrimination for anions over cations. A fairly high permeability
ratio of chloride over sodium with PCl/PNa=24–30 has been reported
for the maxi-anion channel in bovine pigmented ciliary epithelial cells
[107], human T lymphocytes [105], mouse neuroblastoma cells [108], in
neonatal rat cardiac myocytes [109] and mouse mammary C127 cells
[64]. Somewhat lower, but still high PCl/PNa=6–11 was observed in co-
lonic, alveolar and bile duct epithelium [110–112] and in myocytes
[104,113]. It is conceivable that experimental conditions may affect the
measured values of the permeability ratios, and these conditions are
very different in the studies of the maxi-anion channel and VDAC. In
order to reproduce the conditions often used in VDAC papers, we mea-
sured the reversal potential under a 10-fold KCl gradient
(1000mM/100 mM) and obtained a value of about 40 mV for the maxi-
anion channel from mouse ﬁbroblasts [101] yielding PCl/PK=13.5
(Table 1). However, no more than approximately 10 mV (which corre-
sponds to PCl/PK=1.7–1.9) could be measured for mitochondrial VDAC
under the same ionic conditions [102,114]. Much higher anionic selectiv-
ity combinedwith concentration-dependent conductance saturation sug-
gests the existence of a binding site for permeating anions inside the
maxi-anion channel. In contrast, poor discrimination between cations
and anions along with a linear non-saturating conductance is a clear in-
dicative of a large pore with week interaction between channel wall
and permeating ions. Poor selectivity of VDAC for glutamate over chloride
(Pglutamate/PCl=0.45±0.03, Fig. 2D) compared to much better discrimi-
nation with Pglutamate/PCl~0.2 observed under the same experimental
conditions for the maxi-anion channel (Table 1) conﬁrms our conclusion
on crucial differences in the interior of the two channels.
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Fig. 1. Ionic currents activated in the inside-out patches at +25mV after excision from non-transfected control HEK293T cells (A), HEK293T cells transfected with pl-VDAC cDNA (B) and pri-
mary culturedﬁbroblasts isolated from vdac1/vdac3 double knock-outmice (C). Left panels: time courses ofmean patch currents observed after patch excision (at 0 min). Right panels: expand-
ed traces of the currents recordedat indicated time. Currentswere elicitedby steppulses of±25mVevery5 s. Thepipette andbath solutions contained anormal Ringer solutionof the following
composition (mM): 135 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 5 Na-HEPES, 6 HEPES, 5 glucose (pH 7.4, 290 mOsmkg−1 H2O). Representative records of 5 (A), 10 (B) and 9 (C) different patches.
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which is common for the maxi-anion channel and VDAC. In Fig. 3,
we plotted current traces for the two channels recorded in the ionic
environment normally used in the maxi-anion channel patch-clamp
experiments. Both channels inactivated at positive and negative volt-
ages above app. ±20 mV with time-constants of about 50–100 ms at
+50 mV and 300–400 ms at−50 mV. However, an important differ-
ence is the degree of inactivation. While the maxi-anion channel
closes completely, VDAC always retains a large portion (up to 40–
50%) of its amplitude (see histogram of closing events shown in
Fig. 2B and compare the data in Table 1). The so-called “closed”
state has preferential selectivity for cations [7,8]. It should be stressed,
that no such state has ever been reported for the maxi-anion channel.
Table 1 summarizes the biophysical properties of the maxi-anion
channel and VDAC. We believe that the differences are too prominent
to be explained only by a different channel environment in lipid bila-
yers and cellular membranes. The effect of channel environment,
however, can be tested experimentally. The maxi-anion channel is
known to survive after reconstitution in bilayers and giant proteoli-
posomes [115–117]. Fig. 4 illustrates an example of the maxi-anion
channel-like events recorded by patch-clamp upon reconstitution of
detergent-solubilized plasma membrane proteins from mammary
C127 cells into giant proteolyposomes [118]. These events displayed
biophysical properties (such as single-channel conductance of
372 pS, complete voltage-dependent closing at voltages over
±25 mV and Pglutamate/PCl of 0.18) indistinguishable from those ob-
served by patch-clamp on the C127 cells (for comparison, see
Table 1). In these experiments, artiﬁcial membrane composition
(which was made of asolectin from soybean) was very differentfrom that of the excised membrane patches, and the liposomes were
essentially devoid of the most of the auxiliary proteins present in
the patches, suggesting that the maxi-anion channel permeation and
gating are not much affected by surrounding molecular complexes
of the plasmalemma.
Based on the above considerations, we conclude that maxi-anion
channel and VDAC are unrelated proteins. However, this conclusion
by no means rejects the possibility of the plasmalemmal VDAC ex-
pression itself. If expressed on the cellular surface, VDACmay perform
various non-channel functions as described next.
7. VDAC1 as a NADH/NADPH-dependent oxidoreductase
The plasma membranes of many types of cells possess an effective
system for the electron transfer from NADH/NADPH to an acceptor.
Ferricyanide has been shown to replace the physiologically relevant ac-
ceptors (such as O2 or transferrin) and has been widely used for conve-
nient detection of the plasma membrane electron transport (PMET)
activity [119]. Searching for the molecular entity of the ferricyanide re-
ductase, Baker and co-authors [120] solubilized and fractionated the
plasma membrane proteins from human Namalwa cells and, by using
the MALDI-TOF analysis, identiﬁed the protein band associated with
the enzymatic activity as VDAC1. The ferricyanide reductase activity
was high in the pellet immunoprecipitated by anti-VDAC and was
also found in the puriﬁed VDAC protein from rat liver. Importantly,
overexpression of pl-VDAC led to a 40-fold increase in the ferricyanide
reductase activity over the mock-transfected control COS7 cells. The
role of the VDAC-mediated PMET in cell survival and cell death has
been hypothesized [120,121]. Recently, Rao and Rao [122] reported an












































Fig. 2. VDAC channel activity in normal Ringer solution. (A) Single-channel opening amplitude histogram. Major peak corresponds to the single-channel conductance of 530 pS.
Inset shows the representative trace of channel opening recorded at +10 mV. Potential is positive at the side of VDAC addition (“trans”-side), the “cis”-side is maintained at ground.
(B) Histogram of closing events recorded at +50 mV. (C) Current traces of VDAC functioning at different voltages as indicated. Arrowheads show the zero current level for each
trace. (D) Representative single-channel current-to-voltage relationships for the fully open state of the VDAC channel in a symmetrical Ringer solution (open squares) and
when 135 NaCl was replaced with equimolar Na-glutamate in the “trans”-compartment (open circles). Erev=−18.3±1.5 mV (n=5); Pglutamate/PCl=0.45±0.03. Bilayers were
formed of asolectin/cholesterol (10:1 wt/wt) in n-octane. Signals were recorded using an EPC-9-based rig as described elsewhere [64].
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under hypoosmotic stress, and this increase was sensitive to a VDAC in-
hibitor, DIDS, and to inhibitors of the volume-sensitive anion channel,
such as tamoxifen, glibenclamide and ﬂuoxetine. Authors suggested
that VDAC might be in the core of the volume-regulated anion channel.
Ferricyanide is not the only substrate for the VDAC1-mediated re-
ductase activity. Recently, Simamura and co-authors found that re-
duction of quinone antitumor drugs parallels the expression levels
of VDAC1 protein in overexpression and gene silencing experiments
[123–125]. A similar result was obtained by Shimada and co-authors
for a herbicide, paraquat [126]. Although these authors did not
claim contribution of plasmalemmal VDAC, their results may, at
least in part, reﬂect the reductase activity of the pl-VDAC.
It should be noted that recent molecular genetic studies have
revealed a complex structure of the PMET system cored by NADPH/Table 1












Pglutamate/PCl 0.17 [149]; 0.23
(Fig. 4)
PATP/PCl 0.08–0.10 [64]
“Pore-ATP” dissociation constant ~12 mM [64]
Average pore size 1.3 nm [81]
Vestibules pore size 1.16 nm and 1.42
Time constant of voltage-dependent inactivation in normal Ringer
(data of Fig. 3)
114 ms (+50 mV
410 ms (−50 mV
Remaining conductance after full inactivation in normal Ringer
(data of Fig. 3)
1.3% (+50 mV)
5% (−50 mV)NADH-oxidase (NOX) protein family [127]. It is not yet clear what is
the relationship of this newly emerging system with ferricyanide re-
ductase and plasmalemmal VDAC. In order to function as NADH/
NADPH-dependent oxidoreductase, VDAC protein should possess a
nicotinamide adenine dinucleotide binding domain, and such a
motif has indeed been identiﬁed in the VDAC1 primary sequence
around the residues 143–152 [128]. In bilayer experiments, Rostovt-
seva and co-authors [73,74] have clearly detected the nucleotide
binding site in the VDAC channel pore by noise analysis of the channel
open state. Moreover, NADPH was most effective in decreasing the
open-channel current and inducing the excess noise compared to ATP
and other nucleotides with an efﬁciency sequence of β-NADPHN
β-NADH=α-NADHNATPNADPNβ-NAD≥AMPNUTP [74]. However,
little or no NADH binding to the isolated VDAC protein was found in
the concurrent replacement assay by Yehezkel and co-authors [129].nel VDAC
530 pS (data of Fig. 2)
640 pS
0 mM









nm for different entrances [81] 1 nm and 2 nm for different entrances [82,83]
) 55 ms (+50 mV)
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Fig. 3. Comparison of the voltage-dependent inactivation of the maxi-anion channels
(red traces; patch contained ~20 channels) and VDAC (black traces; membrane con-
tained ~18 channels) in a normal Ringer solution. Solid lines are exponential relaxation
ﬁts with parameters shown in Table 1.
Maxi-anion channel records are modiﬁed from [64].
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the electrophysiological experiments is related to the nucleotide-
transporting function of VDAC [70–72,130], but not to its oxidoreduc-
tase activity, which should require much more efﬁcient NADH/NADPH
binding at the micromolar-to-millimolar concentration range.
8. VDAC1 as a receptor for plasminogen kringle 5 and for neuroactive
steroids
Plasminogen is synthesized in liver as a zymogen, released to the
blood stream and further processed to plasmin by proteolytic cleavage.
Plasminogen consists of several kringle domains, and the kringle do-
main 5 confers a capability of high-afﬁnity binding to endothelial cells.
Searching for the molecular identity of the receptor for the kringle 5,
Gonzalez-Gronow and co-authors noticed a sequence homology be-
tween plasminogen activator streptokinase and VDAC1 around the re-
gion of Tyr224–Lys255 [131]. The authors have generated an antibody
against this fragment, which detected the VDAC protein on the surface










Fig. 4.Maxi-anion channel-like activity recorded in giant proteoliposomesmade of asolectin after r
recorded at different voltages as indicated. Arrowheads show the zero current level for each t
lution (open squares; slope conductance 372±9 pS) and when 135 NaCl was replaced wi
(n=5); Pglutamate/PCl=0.18±0.02.
Modiﬁed from [118].of kringle 5 to the cells. Puriﬁed VDAC protein bound the radio-labeled
kringle 5 with a Kd of 22 nM, but only when it was reconstituted into
proteoliposomes. Thus, the plasmalemmally expressed VDAC may
serve as a receptor for kringle 5, which is an important regulator of an-
giogenesis. Kringle 5 has also other receptors, such as glucose-regulated
protein 78, and VDAC is supposed to act in cooperation with them
[132,133]. The precise mechanism of the VDAC-mediated plasminogen
signaling and its physiological/pathophysiological signiﬁcance is not yet
clear and remains to be elucidated.
The pl-VDAC may also function as a receptor for neuroactive preg-
nane steroids and their analogs, which are known to function as anes-
thetics and to modulate GABA-ergic receptors. Darbandi-Tonkabon
and co-authors [134] labeled the brain membrane proteins using a
photoreactive steroid analog, 6-AziP. The compound labeled a 35 kDa
protein identiﬁed as VDAC1 by two-dimensional electrophoresis,
MALDI-TOF and ESI-tandem mass spectrometry analysis. Monoclonal
anti-VDAC antibody immunoprecipitated GABAA receptor subunits,
whichwould imply physical association between the two proteins. Sub-
sequent studies on VDAC knock-out animals conﬁrmed the involve-
ment of VDAC1 and VDAC2 proteins in neuroactive steroid binding
[135]. However, the VDAC-deﬁcient animals and cells derived from
them demonstrated unaltered responses of GABA-ergic receptors to
the steroids, suggesting that steroid–VDAC interaction may have no re-
lation to the GABAA receptor modulation and anesthesia.
9. The maxi-anion channel identity puzzle
The hypothesis of pl-VDAC as molecular correlate of the maxi-
anion channel was one attractive possibility, which now seems not
to be valid in the light of the gene expression results and biophysical
comparison as we discussed above. What are other candidates?
Connexin and closely related pannexin hemichannels are reported
to be involved in the release of ATP and glutamate in some cell types
[136]. Since the same function has been attributes to the maxi-anion
channel, it could be hypothesized that some members of this diverse
protein family could be responsible for the maxi-anion channel activ-
ity. Octanol-1 and carbenoxolone are commonly used as broad spec-
trum inhibitors of both connexins and pannexins. However, the
maxi-anion channel in cardiomyocytes [66] and in mammary C127
cells [5] was not affected by 1 mM octanol-1 applied either from the
intracellular or from the extracellular side. Likewise, the maxi-anion












econstitution of solubilizedmembraneproteins frommammary C127 cells. (A) Current traces
race. (B) Single-channel current-to-voltage relationships in a symmetrical Ringer so-
th equimolar Na-glutamate in the bath solution (open circles). Erev=−33.6±2.5 mV
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unpublished observation). This data would suggest that the maxi-
anion channel, most likely, is not related to connexins or pannexins.
Themaxi-anion channel activity in mammary C127 cells was not af-
fected by atractyloside and bongkrekic acid at 10 μM [5]. These drugs
are well known potent and selective inhibitors of themitochondrial ad-
enine nucleotide translocase (ANT), or ADP/ATP carrier (AAC), which
mediates ATP/ADP exchange at the inner mitochondrial membrane. It
was shown recently, that ANT protein can be detected in the brain syn-
aptosomes [137,138] and forms channels with a conductance of several
hundred pS when reconstituted into giant liposomes [139,140]. Our re-
sult allows us to rule out the possibility that themaxi-anion channel is a
plasmalemmal subtype of the ANT/AAC protein.
Searching for new ion channel candidate genes, Suzuki and
Mizuno [141,142] detected ttyh genes in human genome that are ho-
mologous to the tweety gene in Drosophila ﬂightless locus known to be
involved in normal ﬂying [143]. When heterologously expressed in
CHO cells, the human homolog of tweety, hTTYH3 gave rise to maxi-
anion channel-like currents, which were activated by intracellular
Ca2+ ions. However, when we transfected two splice-variant clones
of the TTYH1 gene (TTYH1-E and TTYH1-SV) into the HEK293T cells,
we could not detect any maxi-anion channel-like activity in the ex-
cised inside-out patches [3]. Further studies will be necessary to
prove or disprove this intriguing hypothesis.
Taken together, we must admit that the molecular entity of the
maxi-anion channel remains enigmatic and requires a fresh start
with new ideas.
10. The maxi-anion channel regulation puzzle
The maxi-anion channel is kept silent in resting state and only
brieﬂy opens in response to various physiologically and pathophysio-
logically relevant stimuli, such as osmotic and salt stress, ischemia,
hypoxia, activation of receptors for endothelin, adenosine, bombesin
and antiestrogens (see for reviews [3–6]). Time-limited activity is im-
portant physiologically, since it provides sufﬁcient ﬂux of the signal-
ing molecules (ATP and glutamate), but does not allow cell
destruction, which could be expected if such a huge pore remains
permanently open. What turns the channel on and off? It is obvious
that a very strict mechanism controls the functional state of the
maxi-anion channel. Since the channel is readily activated by patch
excision, a loss of ATP was supposed to be responsible for the channel










Fig. 5. Maxi-anion channel is inactive in a phosphorylated state (left) and activated by removin
tyrosine residues governs the transition between active and inactive states in mammary C127
Cl−, as well as for negatively charged signaling molecules, such as ATP and glutamate, which iniintracellular ATP drop upon apoptosis [18,22]. However, our studies
suggested that cells die with enhanced levels of the cytosolic free
ATP as monitored by intracellularly expressed luciferase [144,145],
and this is essential in order to execute all the stages of the apoptotic
cell death. Therefore, not ATP itself, but an ATP-dependent process is
a key regulator of the maxi-anion channel.
Once activated, the channel could be closed again by application
of MgATP with a half-maximal efﬁciency of app. 29 μM, whereas a
non-hydrolyzable analog, MgAMP-PNP was ineffective, suggesting
that phosphorylation keeps the maxi-anion channel in inactive
state [146]. Using a full set of available pharmacological tools, Toy-
chiev and co-authors found that tyrosine rather than Ser/Thr phos-
phorylation is a principal regulatory factor in mammary C127 cells
and mouse ﬁbroblasts [146]. Gene knock-out and gene knock-in ex-
periments revealed a receptor type protein tyrosine phosphatase,
RPTPζ, as a major part of the activation machinery of the maxi-
anion channel [146]. This inference is in contrast to the observation
on C1300 neuroblastoma cells, where the antiestrogen-activated
maxi-anion channel whole-cell currents were blocked by okadaic
acid, a broad spectrum inhibitor of Ser/Thr phosphorylation [147].
Note that okadaic acid was ineffective in mammary C127 cells
[146], thus the way the channel is regulated by phosphorylation
should be highly cell-speciﬁc.
Besides the protein phosphorylation, a list of regulatory factors
of the maxi-anion channel includes intracellular calcium ions, cyto-
skeleton and G-proteins. The results obtained on different cells
types are contradictory and sometimes even opposite to each
other (see for reviews [3,6]). We believe that only molecular iden-
tiﬁcation of the maxi-anion channel will make it possible to unam-
biguously solve the puzzle of the maxi-anion channel regulation
mechanism.
11. Concluding remarks
The idea of the extramitochondrial expression of VDAC protein
and the hypotheses about its possible functions on the cell surface
have been stimulating and have brought about much excitement in
the ﬁeld. At ﬁrst glance, VDAC protein reproduced the most important
biophysical properties of the maxi-anion channel, but these similari-
ties turned out to be superﬁcial. We must admit that the hypothesis
of plasmalemmal VDAC as the maxi-anion channel has oversimpliﬁed
the real situation and did not withstand the genetic test. We believe



















g the phosphate group(s) upon swelling, ischemia and hypoxia (right). Phosphorylation of
cells and skin ﬁbroblasts [146]. Once active, the pore serves as a conducting pathway for
tiate downstream stress-sensory signal transduction. See text for details.
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roids” should also be scrutinized by geneticmanipulations of VDACpro-
tein expression. Basically, the very presence of the VDAC protein on the
cellular plasma membrane should also respond to the genetic manipu-
lations and needs to be veriﬁed in future investigations.
Similar to VDAC, maxi-anion channel possesses a wide pore capa-
ble to pass nucleotides and excitatory amino acids. When the channel
opens in stimulated cells, small, but physiologically relevant amounts
of ATP and glutamate are released to the extracellular space in order
to bring a message to the neighboring cells about the physiological
state of the emitter. In diseased tissues, this signal is overwhelmingly
loud and either serves to protect the organs (as ATP during cardiac is-
chemia) or causes the cell death, as it occurs for glutamate-induced
excitotoxicity and neurodegeneration in the brain deprived of oxygen
and glucose or injured by trauma. Our current knowledge about the
maxi-anion channel properties and functions is summarized in
Fig. 5. We anticipate that after being identiﬁed at the molecular
level, the maxi-anion channel will represent an important target for
drug discovery and for developing new strategies of treatment of is-
chemia-related pathologies.
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